Results 111 to 120 of about 26,143 (169)

改良新辅助放化疗加术中温热灌洗治疗低位直肠癌的临床应用

open access: yesZhongshan Daxue xuebao. Yixue kexue ban, 2010
【目的】 评估低位直肠癌手术前行改良新辅助放化疗+术中温热灌洗治疗的近期疗效及肿瘤的病理学改变,探索治疗低位直肠癌的新途径65377;【方法】 45例低位直肠癌患者DukesB期(17)65380;DukesC期(28)随机分为:A组15例行自行设计改良的新辅助治疗:术前放疗65380;区域动脉介入微泵灌注化疗,按时辰多通道程控输液泵给药;B组15例,术前放疗+区域动脉介入一次性灌注化疗;C组15例诊断明确后手术;45例患者均行术中腹腔温热灌洗化疗65377;【结果】 A65380;B65380 ...
doaj  

[Analysis of efficacy and prognosis of neoadjuvant chemotherapy and (or) surgery plus radiotherapy for hypopharyngeal squamous cell carcinoma]. [PDF]

open access: yesLin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, 2023
Xiao Q   +6 more
europepmc   +1 more source

[The value of DCE-MRI combined with spectral CT in the short-term efficacy of concurrent chemoradiotherapy for nasopharyngeal carcinoma]. [PDF]

open access: yesLin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi
Zheng S   +5 more
europepmc   +1 more source

[Comparison of different laryngeal preservation strategies based on chemoradiotherapy in locally advanced hypopharyngeal carcinoma]. [PDF]

open access: yesLin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, 2023
Luo X   +12 more
europepmc   +1 more source

PIK3CA突变对结直肠癌患者血液学改变及预后的影响

open access: yesZhongguo shiyan zhenduanxue
目的探讨PIK3CA突变的结直肠癌患者接受辅助化疗后血液学改变及对预后的影响。方法回顾性分析2007年1月到2012年12月就诊于解放军第960医院行辅助化疗的结直肠癌患者病例资料,比较PIK3CA突变组与野生组患者行一线辅助化疗方案结束时的外周血指标,从而探讨PIK3CA突变对血液学指标及预后的影响。结果共收集到364例患者,PIK3CA突变组与野生组在性别、年龄、位置、分化、肿瘤位置、分期、淋巴结转移等无明显差异。PIK3CA突变患者化疗疗效更差,DFS(无病生存期,Disease-free ...
郭昭君   +9 more
doaj  

[Matrix stiffening related lncRNA SNHG8 regulates chemosensitivity of ovarian cancer]. [PDF]

open access: yesSheng Wu Yi Xue Gong Cheng Xue Za Zhi, 2023
Cheng Z, Ma X, Zhang Q, Chen W.
europepmc   +1 more source

Home - About - Disclaimer - Privacy